Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
1.01M
-
Shares change
-
+105K
-
Total reported value, excl. options
-
$2.12M
-
Value change
-
+$214K
-
Number of buys
-
11
-
Number of sells
-
-8
-
Price
-
$2.10
Significant Holders of Dare Bioscience, Inc. - COM NEW (DARE) as of Q3 2025
26 filings reported holding DARE - Dare Bioscience, Inc. - COM NEW as of Q3 2025.
Dare Bioscience, Inc. - COM NEW (DARE) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.01M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (395K shares), AMH Equity Ltd (232K shares), GEODE CAPITAL MANAGEMENT, LLC (123K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (60.2K shares), RENAISSANCE TECHNOLOGIES LLC (58.9K shares), STATE STREET CORP (23.5K shares), UBS Group AG (22.6K shares), Virtu Financial LLC (17.7K shares), BlackRock, Inc. (17K shares), and RAYMOND JAMES FINANCIAL INC (15.3K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.